Alterations of signaling pathways in muscle tissues of patients with amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 46, Issue 6, 2012, Pages 856-860

  Yin, Fei ^a   Ye, Fei ^b   Tan, Limei ^a   Liu, Katherine ^b   Xuan, Zhaopeng ^a   Zhang, Jinnan ^a   Wang, Wenhu ^a   Zhang, Yanli ^a   Jiang, Xinmei ^a   Zhang, David Y ^b  

^a JILIN UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Diagnosis; Lower motor neuron disease; Prognosis; Protein pathway array; Proteomics; Spinal muscular atrophy

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 13B; CYCLIN DEPENDENT KINASE 4; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHODIESTERASE I; PHOSPHOPROTEIN; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P53; PROTEIN P70; STEROID RECEPTOR COACTIVATOR 1;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME PHOSPHORYLATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION;

EID: 84870157068     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23411     Document Type: Article

References (29)

1. Bowser R, Lacomis D. Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle Nerve 2009; 40: 753-762.
2. Zhang DY, Ye F, Gao L, Liu X, Zhao X, Che Y, et al. Proteomics, pathway array and signaling network-based medicine in cancer. Cell Div 2009; 4: 20.
3. Zerres K, Davies KE. 59th ENMC International Workshop: Spinal Muscular Atrophies: Recent Progress and Revised Diagnostic Criteria 17-19 April 1998, Soestduinen, The Netherlands. Neuromuscul Disord 1999; 9: 272-278.
4. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. ubcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124( suppl): 96-107.
5. Wang D, Ye F, Sun Y, Li W, Liu H, Jiang J, et al. Protein signatures for classification and prognosis of gastric cancer: a signaling pathway-based approach. Am J Pathol 2011; 179: 1657-1666.
6. Ye F, Che Y, McMillen E, Gorski J, Brodman D, Saw D, et al. The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells. Nutr Cancer 2009; 61: 530-537.
7. Mulder DW. Clinical limits of amyotrophic lateral sclerosis. Adv Neurol 1982; 36: 15-22.
8. Kimura T, Takahashi MP, Okuda Y, Kaido M, Fujimura H, Yanagihara T, et al. The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy. Neurosci Lett 2000; 295: 93-96.
9. Offen D, Barhum Y, Melamed E, Embacher N, Schindler C, Ransmayr G. Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J Mol Neurosci 2009; 38: 85-93.
10. Nguyen MD, Boudreau M, Kriz J, Couillard-Despres S, Kaplan DR, Julien JP. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J Neurosci 2003; 23: 2131-2140.
11. Kihira T, Suzuki A, Kondo T, Wakayama I, Yoshida S, Hasegawa K, et al. Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients. Neuropathology 2009; 29: 548-558.
12. Lanius RA, Paddon HB, Mezei M, Wagey R, Krieger C, Pelech SL, et al. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J Neurochem 1995; 65: 927-930.
13. Ranganathan S, Bowser R. p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS. Open Pathol J 2010; 4: 11-22.
14. Ranganathan S, Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 2003; 162: 823-835.
15. Gullaud M, Delanoue R, Silber J. A Drosophila model to study the functions of TWIST orthologs in apoptosis and proliferation. Cell Death Differ 2003; 10: 641-651.
16. Hatoko M, Niitsuma K, Tanaka A, Kuwahara M, Iioka H. Expression of N-cadherin by skeletal muscle in the degeneration and the degeneration/regeneration processes after nerve injury. Scand J Plast Reconstr Surg Hand Surg 2004; 38: 198-203.
17. Nakano S, Shimohama S, Saitoh T, Akiguchi I, Kimura J. Localization of protein kinase C in human skeletal muscle. Muscle Nerve 1992; 15: 496-499.
18. Noh KM, Hwang JY, Shin HC, Koh JY. A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol Dis 2000; 7: 375-383.
19. Hu JH, Zhang H, Wagey R, Krieger C, Pelech SL. Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J Neurochem 2003; 85: 432-442.
20. Sneddon AA, Delday MI, Maltin CA. Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-alpha activity. Am J Physiol Endocrinol Metab 2000; 279: E188-195.
21. Lin Y, Brady MJ, Wolanske K, Holbert R, Ruderman NB, Yaney GC. Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle. Am J Physiol Endocrinol Metab 2002; 283: E318-325.
22. Zhang JM, Zhao X, Wei Q, Paterson BM. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J 1999; 18: 6983-6993.
23. Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, Gordon PH, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005; 64: 38-43.
24. Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009; 8: 94-109.
25. Mitchell RM, Simmons Z, Beard JL, Stephens HE, Connor JR. Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve 2010; 42: 95-103.
26. Soriani MH, Desnuelle C. Epidemiology of amyotrophic lateral sclerosis [in French]. Rev Neurol (Paris) 2009; 165: 627-640.
27. Biswas A, Ivaskevicius V, Seitz R, Thomas A, Oldenburg J. An update of the mutation profile of Factor 13 A and B genes. Blood Rev 2011; 25: 193-204.
28. Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 2011; 1: 4.
29. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, et al. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 2006; 576: 923-933.